Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

Share Price is delayed by 15 minutes
Get Live Data
303.00    1.00 (0.33%)
Bid:
301.00
Ask:
303.00
Spread: 2.00 (0.664%)
Market Cap: £357.21m
DIG Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Inc. Share Chart

Board Changes

31 Jan 2025 10:43

RNS Number : 4807V
Dunedin Income Growth Inv Tst PLC
31 January 2025
 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier (LEI): 549300PPXLZPR5JTL763

 

 

 

31 January 2025

 

 

Board Changes

The Board of Dunedin Income Growth Investment Trust PLC (the "Company") is pleased to announce the appointment of Arun Kumar Sarwal as an independent non-executive Director of the Company with effect from 1 February 2025. 

 

Arun Kumar Sarwal is a Chartered Accountant and has broad experience of global equities and fund management over some 35 years in the UK, Europe, and Asia. He is a Board Advisor to Tumelo and a director and Chairman of the Audit Committee of JPMorgan European Discovery Trust plc. His previous roles include CEO of Broadridge Fund Communication Solutions, Senior Vice President of SS&C Technologies, COO and CFO at Scottish Widows Investment Partnership and global roles at ABN AMRO and Societe Generale Investment Bank.

 

Arun will stand for election at the Annual General Meeting to be held in May 2025. There are no other disclosures required under Section 6.4.8 of the FCA's Listing Rules in relation to this appointment.

 

As previously stated, Jasper Judd and David Barron, who both joined the Board in February 2016 will retire as Directors at the conclusion of the Company's Annual General Meeting in May. It is the Board's intention that Arun Kumar Sarwal will be appointed as Chairman of the Audit Committee in place of Jasper Judd at that time. As previously stated, Howard Williams, who has been a Director since April 2018, will succeed David Barron as Chair of the Company following the AGM.

 

It is the Board's intention to recruit a further Director in 2025 to bring the number of Directors back to five.

 

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKDBQKBKDBDN
Date   Source Headline
15th Jul 202511:37 amRNSNet Asset Value(s)
14th Jul 20252:15 pmRNSGearing disclosure
14th Jul 202512:30 pmRNSNet Asset Value(s)
11th Jul 202511:57 amRNSNet Asset Value(s)
10th Jul 202511:44 amRNSNet Asset Value(s)
9th Jul 20252:46 pmRNSPortfolio Disclosures
9th Jul 202512:16 pmRNSNet Asset Value(s)
8th Jul 202511:09 amRNSNet Asset Value(s)
7th Jul 20252:53 pmRNSGearing Disclosures
7th Jul 202512:00 pmRNSNet Asset Value(s)
4th Jul 202511:32 amRNSNet Asset Value(s)
4th Jul 202511:11 amRNSMonth End Net Asset Value(s)
3rd Jul 202512:33 pmRNSNet Asset Value(s)
2nd Jul 20255:11 pmRNSTransaction in Own Shares
2nd Jul 202512:29 pmRNSNet Asset Value(s)
1st Jul 20259:53 amRNSTotal Voting Rights
30th Jun 20255:05 pmRNSTransaction in Own Shares
30th Jun 20253:16 pmRNSGearing disclosure
30th Jun 202512:21 pmRNSNet Asset Value(s)
27th Jun 20255:11 pmRNSTransaction in Own Shares
27th Jun 20251:25 pmRNSNet Asset Value(s)
26th Jun 20255:16 pmRNSTransaction in Own Shares
26th Jun 20251:29 pmRNSFirst Interim Dividend
26th Jun 202511:10 amRNSNet Asset Value(s)
25th Jun 20255:09 pmRNSTransaction in Own Shares
25th Jun 202512:26 pmRNSNet Asset Value(s)
24th Jun 20255:08 pmRNSTransaction in Own Shares
24th Jun 202512:05 pmRNSNet Asset Value(s)
24th Jun 20257:00 amRNS-RKepler Trust Intelligence: New Research
23rd Jun 20255:07 pmRNSTransaction in Own Shares
23rd Jun 20253:35 pmRNSGearing disclosure
23rd Jun 20253:05 pmRNSNet Asset Value(s)
20th Jun 20255:23 pmRNSTransaction in Own Shares
20th Jun 202512:00 pmRNSNet Asset Value(s)
19th Jun 202512:29 pmRNSNet Asset Value(s)
18th Jun 20255:30 pmRNSTransaction in Own Shares
18th Jun 202512:39 pmRNSNet Asset Value(s)
17th Jun 20255:20 pmRNSTransaction in Own Shares
17th Jun 202512:46 pmRNSDirector/PDMR Shareholding
17th Jun 202512:18 pmRNSNet Asset Value(s)
16th Jun 20255:14 pmRNSTransaction in Own Shares
16th Jun 20252:21 pmRNSGearing Disclosures
16th Jun 202512:32 pmRNSNet Asset Value(s)
16th Jun 202510:11 amRNSDirector/PDMR Shareholding
13th Jun 20255:11 pmRNSTransaction in Own Shares
13th Jun 202512:15 pmRNSNet Asset Value(s)
12th Jun 20255:12 pmRNSTransaction in Own Shares
12th Jun 202512:54 pmRNSNet Asset Value(s)
11th Jun 20255:10 pmRNSTransaction in Own Shares
11th Jun 20255:05 pmRNSPortfolio Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.